PUBLICACIÓN
Dihydrofolate reductase genetic polymorphisms affect methotrexate dose requirements in pediatric patients with acute lymphoblastic leukemia on maintenance therapy
Gervasini G., De Murillo S.G., Jimenez M., De La Maya M.D., Vagace J.M.
2017 Journal of Pediatric Hematology/Oncology
Hematology (Q3), Oncology (Q3), Pediatrics, Perinatology and Child Health (Q2)
JCR: 1.06
SJR: 0.459
CITAS
10
DOI
10.1097/mph.0000000000000908
EID
2-s2.0-85024502614
ISSN
1077-4114
EISSN
1536-3678
BIBTEX
@article{PMID:28719513, title = {Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.}, author = {Gervasini G and de Murillo SG and Jiménez M and de la Maya MD and Vagace JM}, doi = {10.1097/mph.0000000000000908}, journal = {Journal of pediatric hematology/oncology}, month = {11}, year = {2017} }
AUTORES DE LA UEX